Geron (GERN) Gains from Sales and Divestitures (2012 - 2018)
Geron's (GERN) quarterly Gains from Sales and Divestitures came in at $73980.0 in Q4 2018, up 2.66% year-on-year from $72066.0 in Q4 2017, and up 2.66% quarter-over-quarter from $72066.0 in Q4 2017.
Geron (GERN) Gains from Sales and Divestitures (2012 - 2018) Analysis & Trends
Geron has disclosed Gains from Sales and Divestitures across 7 years of filings, most recently posting $73980.0 for Q4 2018.
- Gains from Sales and Divestitures for Q4 2018 came in at $73980.0, up 2.66% year-over-year; the trailing twelve-month figure through Dec 2018 was $73980.0 (up 2.66% YoY), and the FY2018 annual result was $73980.0, up 2.66% from the prior year.
- Gains from Sales and Divestitures came in at $73980.0 for Q4 2018 at Geron, up from $72066.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $265422.0 in Q4 2014 to a low of $22041.0 in Q4 2016.
- The 5-year median for Gains from Sales and Divestitures is $73860.0 (2015), against an average of $101473.8.
- Across the five-year window, Gains from Sales and Divestitures slumped 72.17% in 2015 and jumped 226.96% in 2017, its largest moves.
- Geron's Gains from Sales and Divestitures stood at $265422.0 in 2014, then plunged by 72.17% to $73860.0 in 2015, then sank by 70.16% to $22041.0 in 2016, then surged by 226.96% to $72066.0 in 2017, then climbed by 2.66% to $73980.0 in 2018.
- The last three Gains from Sales and Divestitures figures came in at $73980.0 (Q4 2018), $72066.0 (Q4 2017), and $22041.0 (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 73,980.00 |
| Dec 31, 2018 | 73,980.00 |
| Dec 31, 2017 | 72,066.00 |
| Dec 31, 2017 | 72,066.00 |
| Dec 31, 2016 | 22,041.00 |
| Dec 31, 2016 | 22,041.00 |
| Dec 31, 2015 | 73,860.00 |
| Dec 31, 2015 | 73,860.00 |
| Dec 31, 2014 | 265,422.00 |
| Dec 31, 2014 | 265,422.00 |
| Dec 31, 2013 | 134,091.00 |
| Dec 31, 2013 | 134,091.00 |
| Dec 31, 2012 | 643,775.00 |
| Dec 31, 2012 | 643,775.00 |